bpc-157 current status fda approval 2026 The Food and Drug Administration's committee on compounded drugs broke with agency scientists and voted in favor of adding peptides to the list of substances compounding pharmacies can make. Follow the link A step towards expanded patient
A step towards expanded patient access. This will allow patients to have conversations about these compounds in the clinical setting instead of resorting to a gray market without practitioner oversight or monitoring! Exciting news for peptides coming out of today's committee hearing! The FDA Pharmacy Compounding Advisory Committee voted 8 6 to recommend adding BPC 157 to the 503A Bulks List for use in compounding for FDA reviews BPC 157, TB 500 and other peptides favored by RFK Jr. AP News Peptides in 2026, what RFK Jr.'s announcement means for BPC 157 Raleigh News & Observer FDA's Review Of Peptides Signals A Growing Public Health Challenge BPC 157 just got voted in favor to be added to the 503A Bulk Drug Substances list, meaning a huge step towards being able to be prescribed and compounded in the US. Thank
Pay in 4 interest-free payments of $5.21 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2

